Model
Edge
Centessa Pharmaceuticals
CNTA
Filing type
8-K
Filing date
Jun 23, 2026
Updated
Jun 24, 2026 ยท 7:00 AM
Copy reference
Filing
8-K
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Other Events